Ovid Therapeutics Inc. OVID
2.26 USD +0.04 (+1.80%)
Regular-session close
2.26 0.00 0.00%
After hours · Nov 18, 4:00 PM ET
2.17 Day range 2.32
1.21 52-week range 3.11
- YTD
- +38.65%
- 1 year
- +71.21%
News
defenseworld.net Ovid Therapeutics Sets Up 2027 Data Tests for Epilepsy and Brain Drug Programs Ovid Therapeutics (NASDAQ: OVID) is advancing multiple clinical studies of its experimental brain medicines, with data from two programs expected in 2027, CEO Meg Alexander said during a discussion…
seekingalpha.com Ovid Therapeutics Inc. (OVID) Presents at UBS Global Biopharma Conference 2026 Prepared Remarks Transcript Ovid Therapeutics Inc. ( OVID ) UBS Global Biopharma Conference 2026 November 16, 2026 9:40 AM EST Company Participants Meg Alexander - CEO, President & Director Conference Call Participants Aidan…benzinga.com Ovid Therapeutics Q3 EPS $(0.10) Misses $(0.09) Estimate Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.09) by 11.11 percent. This is a 41.18 percent increase over losses of…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Karyopharm Therapeutics (NASDAQ:KPTI) stock moved upwards by 10.0% to $0.04 during Monday's after-market session. The company's market cap stands at $1.2 million. Fractyl Health (NASDAQ:GUTS)…
